Valiant Laboratories PB Ratio

Valiant Laboratories Ltd Price to Book Ratio

The Valiant Laboratories Ltd Price to Book Ratio is a key financial metric used by investors to evaluate Valiant Laboratories Ltd's valuation, profitability, and overall financial performance. Tracking the Valiant Laboratories Ltd Price to Book Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Valiant Laboratories Ltd (NSE: VALIANTLAB, BSE: 543998) is currently trading at ₹57.28, with a market capitalization of ₹3.09B. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Valiant Laboratories Ltd Price to Book Ratio is essential for fundamental analysis.

Valiant Laboratories Ltd Price to Book Ratio Current Value

The current Valiant Laboratories Ltd Price to Book Ratio stands at 1.42.

The Valiant Laboratories Ltd Price to Book Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.

Valiant Laboratories Ltd Price to Book Ratio Historical Trend

The Valiant Laboratories Ltd Price to Book Ratio has shown the following historical trend:

• 2024: 1.42
• 2023: 2.67
• 2022: 0
• 2021: 0
• 2020: 0

The decline in Valiant Laboratories Ltd Price to Book Ratio indicates improving financial efficiency or better earnings growth.

What Valiant Laboratories Ltd Price to Book Ratio Indicates for Investors

The Valiant Laboratories Ltd Price to Book Ratio plays a crucial role in understanding the company's financial health and valuation.

The P/B ratio shows how the market values company assets relative to book value.

Valiant Laboratories Ltd Price to Book Ratio Analysis Summary

The Valiant Laboratories Ltd Price to Book Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Valiant Laboratories Ltd Price to Book Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Valiant Laboratories Ltd Price to Book Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.